Live Breaking News & Updates on Retinopathy Pipeline Insight

Stay updated with breaking news from Retinopathy pipeline insight. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

New treatment targeting aging cells could offer lasting relief for diabetic macular edema

Targeting senescent cells in the retina with a BCL-xL inhibitor shows promise as a durable treatment for diabetic macular edema, potentially offering long-term visual function improvements. ....

Anukool Manoton , Nature Medicine , Diabetic Macular Edema , Macular Edema , Blood Vessels , Diabetic Retinopathy , Growth Factor , Vision Loss ,

Groundbreaking technology shows immense potential for treating ischemic retinopathy

A groundbreaking technology with immense potential in treating ischemic retinopathy in premature infants and diabetic patients has been developed by Professor Byoung Heon Kang and his research team in the Department of Biological Sciences at UNIST, in collaboration with Professor Dong Ho Park's team at Kyungpook National University Hospital. Ischemic retinopathy, characterized by the breakdown of the blood-retinal barrier and abnormal blood vessel growth, often leads to vision impairment and loss. ....

South Korea , Smartin Bio Inc , Department Of Biological Sciences , Kyungpook National University Hospital , Ulsan National Institute Of Science , National Institute , Professor Byoung Heon Kang , Biological Sciences , Professor Dong Ho Park , Kyungpook National University , Byoung Heon Kang , Advanced Science , Mid Career Research Program , Korea Drug Development Fund , Blood Vessel , Tumor Necrosis Factor ,